Overview

  • Product nameAnti-C2orf57 antibody
  • Description
    Mouse polyclonal to C2orf57
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Full length Human C2orf57 protein (NP_689827.1, 1 a.a. ~ 395 a.a).

  • Positive control
    • C2orf57 transfected 293T cell lysate.

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage bufferPreservative: None
    Constituents: Whole serum
  • PurityWhole antiserum
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab73059 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/500 - 1/1000. Predicted molecular weight: 42 kDa.

Target

  • RelevanceC2orf57 is an uncharacterized protein.
  • Database links
  • Alternative names
    • Chromosome 2 open reading frame 57 antibody
    • Hypothetical protein LOC165100 antibody
    • MGC35154 antibody
    • Uncharacterized protein C2orf57 antibody

Anti-C2orf57 antibody images

  • All lanes : Anti-C2orf57 antibody (ab73059) at 1/500 dilution

    Lane 1 : C2orf57 transfected 293T cell lysate
    Lane 2 : Non-transfected 293T cell lysate

    Lysates/proteins at 25 µg per lane.

    Secondary
    Goat Anti-Mouse IgG (H&L)-HRP Conjugate at 1/2500 dilution

    Predicted band size : 42 kDa
    Observed band size : 50 kDa (why is the actual band size different from the predicted?)

References for Anti-C2orf57 antibody (ab73059)

ab73059 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab73059.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"